Relative risk for tetramer thresholds and days after transplantation
| . | Relative risk (95% CI) . | Subjects above cutoff, %* . | P . |
|---|---|---|---|
| Days after transplantation, using a tetramer threshold of 7 cells/μL | |||
| 60 | 2.46 (1.1-5.5) | 19 | .014 |
| 65 | 2.83 (1.3-6.3) | 18 | .004 |
| 70 | 2.13 (1.1-4.3) | 22 | .023 |
| 100 | 1.98 (1.0-3.8) | 24 | .031 |
| Tetramer thresholds, cells/μL, on day 65 | |||
| 2 | 1.74 (0.9-3.2) | 28 | .072 |
| 3 | 1.81 (1.0-3.4) | 27 | .056 |
| 4 | 2.22 (1.1-4.3) | 23 | .014 |
| 5 | 2.51 (1.2-5.1) | 21 | .006 |
| 6 | 2.51 (1.2-5.1) | 21 | .006 |
| 7 | 2.83 (1.3-6.3) | 18 | .004 |
| 8 | 2.26 (1.0-5.0) | 20 | .023 |
| 9 | 2.14 (1.0-4.7) | 21 | .034 |
| 10 | 2.02 (0.9-4.4) | 21 | .049 |
| . | Relative risk (95% CI) . | Subjects above cutoff, %* . | P . |
|---|---|---|---|
| Days after transplantation, using a tetramer threshold of 7 cells/μL | |||
| 60 | 2.46 (1.1-5.5) | 19 | .014 |
| 65 | 2.83 (1.3-6.3) | 18 | .004 |
| 70 | 2.13 (1.1-4.3) | 22 | .023 |
| 100 | 1.98 (1.0-3.8) | 24 | .031 |
| Tetramer thresholds, cells/μL, on day 65 | |||
| 2 | 1.74 (0.9-3.2) | 28 | .072 |
| 3 | 1.81 (1.0-3.4) | 27 | .056 |
| 4 | 2.22 (1.1-4.3) | 23 | .014 |
| 5 | 2.51 (1.2-5.1) | 21 | .006 |
| 6 | 2.51 (1.2-5.1) | 21 | .006 |
| 7 | 2.83 (1.3-6.3) | 18 | .004 |
| 8 | 2.26 (1.0-5.0) | 20 | .023 |
| 9 | 2.14 (1.0-4.7) | 21 | .034 |
| 10 | 2.02 (0.9-4.4) | 21 | .049 |
CI indicates confidence interval.
Percentage of subjects above cutoff with CMV infection.